The Waterloo Institute for Nanotechnology (WIN) is a global leader in discovering and developing smart and functional materials, connected devices, next generation energy systems, and therapeutics and theranostics. These discoveries by our scientists and engineers are fundamentally changing our world and helping solve some of humanity's most pressing issues. Our 285, 000 square foot, state-of-the-art facility meets the highest scientific standards for the control of vibration, electromagnetic radiation, temperature, and humidity, making it a global centre of excellence for nanotechnology and its applications.
Why is nanotechnology important? It is about creating new materials and improving ways of manufacturing products. To be more efficient, better, stronger and cheaper. Also improving the economy, environment and society. To achieve societal impact and a sustainable future, WIN has now mapped its thematic areas with the United Nations Sustainable Development Goals.
News
Researchers awarded over $180,000 for tools, equipment
Two Waterloo Institute for Nanotechnology members will receive a total of almost $185,000 under a federal program designed to give exceptional researchers the tools and equipment needed to become leaders in their fields.
The recipients are among 21 researchers campus-wide at the University of Waterloo announced today for almost $2.66 million in backing through the Canada Foundation for Innovation’s John R. Evans Leaders Fund.
Across the country, $77 million will go to support 332 research infrastructure projects at 50 universities.
WIN member cited for one of 2020’s top PNAS research papers
A WIN member was recently honoured by the National Academy of Sciences of America for research involving a gel-like robot, inspired by sea slugs and snails, that is steerable by light.
Hamed Shahsavan, who joined Waterloo as a professor of chemical engineering last year, was lead author of a paper chosen as a finalist for a Cozzarelli Prize recognizing the top work published by the Proceedings of the National Academy of Sciences (PNAS) in 2020.
Developing inks to 3D print cells and tissue structures
To a scientist, trial and error are common in laboratories to refine new tests and methods and look for potential problems on the small scale. But what happens when these techniques are meant for human tissues, such as for surgeries, medical tests, and treatments, where multiple different trials are not possible?